Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU) (EXTUBATE)

April 29, 2024 updated by: Abraham Schoe, MD, PhD., Leiden University Medical Center

Oxygen Consumption (VO2), Effort, and Weaning in the Mechanically Ventilated Patient in the Intensive Care Unit (ICU): EXTUBATE Study

In patients who are mechanically ventilated for more than 72 hours weaning failure is a common issue. The Spontaneous breathing trial (SBT) is often done to assess if the patient can be extubated with a high chance of success. However, re-intubation rates are between 15 - 20 % after a successful SBT. The rapid shallow breathing index (RSBI) is an important parameter used in an SBT. Because the high incidence of extubation failure (re-intubation within 48 hours) a search for a better parameter than the RSBI is warranted. Using the measured end-tidal oxygen (etO2) of mechanically ventilated patients it is possible to calculate the VO2, which is a measure of patient effort. The VO2 is a parameter with the potential to predict weaning success or failure, together with other parameters of patient effort like the work of breathing (WOB), pressure time product (PTP) and esophageal pressure swings, reflecting muscle strength of the diaphragm. Therefore, the investigators want to investigate if these parameters are associated with an SBT success or failure.

Study Overview

Detailed Description

Weaning failure is a common problem in patients who are mechanically ventilated for more than 72 hours. Prediction of successful extubation is crucial for mechanically ventilated (MV) intensive care patients. Prolonged intubation leads to prolonged mechanical ventilation, which is known to have undesirable and detrimental effects. Premature extubation, on the other hand, is associated with clinical deterioration, a second episode of mechanical ventilation, and prolonged mechanical ventilation, resulting in multiple adverse outcomes.

In addition, up to 20% of all Intensive Care Unit (ICU) patients fail to wean from mechanical ventilation. Prolonged mechanical ventilation is associated with half of the total time spent on the ICU. Improving the prediction of successful weaning provides physicians with a mean to optimize extubation timing, while reducing the incidence of premature extubation.

The rapid shallow breathing index (RSBI) is a parameter commonly used to predict extubation success, next to some other clinical parameters such as consciousness level, the ability to cough and muscle strength. The most commonly used RSBI cut-off value for predicting save extubation incorrectly classifies 15% to 20% of patients. Which means that those patients require another period of mechanical ventilation with possible adverse consequences. It is therefore necessary to develop new parameters or indices aiding in the guidance of extubation timing.

Various other parameters, such as work of breathing (WOB), transpulmonary pressure swings (PS) and the pressure time product (PTP), which are manifestations of patient effort, have been investigated. Although a difference in transpulmonary pressure swings during a spontaneous breathing trial (SBT) has been linked to weaning failure, it has yet to be determined whether transpulmonary pressure swings predict extubation success or failure. For all these measures of effort the placement of an esophageal catheter is obligatory.

Oxygen consumption (VO2) is a direct manifestation of patient effort. It is defined as the difference between the amount of oxygen inhaled and exhaled over a predetermined time interval. Using end tidal oxygen (etO2) measurements and volumetric calculations, it is feasible to track VO2 variations breath-by-breath. A change in oxygen consumption during an SBT could be an early indicator of patient effort and failure.

The investigators hypothesize that VO2 measurement, together with indices of patient effort, could be valuable additional parameters when estimating weaning failure or success, and therefore, aid in the prediction of extubation success or failure.

Study Type

Observational

Enrollment (Estimated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Florence E Smits, MSc
  • Phone Number: +31 (0)71-5262164
  • Email: f.e.smits@lumc.nl

Study Locations

      • Leiden, Netherlands, 2333ZA
        • Not yet recruiting
        • Leiden University Medical Center
        • Contact:
        • Contact:
    • Zuid - Holland
      • Leiden, Zuid - Holland, Netherlands, 2333 ZA
        • Recruiting
        • Leiden University Medical Centre
        • Contact:
          • Abraham Schoe, MD, PhD
          • Phone Number: +32-715265018
          • Email: a.schoe@lumc.nl
        • Principal Investigator:
          • Abraham Schoe, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The intended population consists of adults who are mechanically ventilated in the ICU and meet the criteria for a regular spontaneous breathing trial according to the ruling LUMC protocol.

Description

Inclusion Criteria:

  • Age above 18 years
  • > 24 hours mechanically ventilated
  • Eligible for a spontaneous breathing trial according to the clinical team
  • Regular SBT ("Regulier SBT") according to the Leiden University Medical Center (LUMC) protocol
  • Hemodynamically stable
  • Esophageal Catheter in situ

Exclusion Criteria:

  • Severe chronic obstructive pulmonary disease (COPD) (Gold class IV) if it results in a non regular SBT according to the LUMC protocol.
  • Heart failure (LVEF <30%) if it results in a non regular SBT according to the LUMC protocol
  • Known pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spontaneous Breathing Trial
Patients who will undergo a spontaneous breathing trial
Patients will undergo an SBT to determine whether they are ready for extubation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of weaning failure
Time Frame: 48 hours after SBT
weaning failure is defined as not meeting the criteria for a succesful spontaneous breathing trial (SBT) or extubation failure, defined as the need for re-intubation within 48 hours, after a succesful SBT and subsequent extubation.
48 hours after SBT
Differences of oxygen consumption during SBT
Time Frame: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
The values of oxygen consumption (in milliliter/minute) and the differences between start, during, and end of the SBT.
10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Differences of esophageal pressure swings measured with an esophageal catheter during SBT
Time Frame: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
The values of pressure swings (in cmH2O), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.
10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
Differences of work of breathing measured with an esophageal catheter during SBT
Time Frame: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
The values of work of breathing (in Joules/liter), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.
10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
Differences of pressure time product measured with an esophageal catheter during SBT
Time Frame: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
The values of pressure time product (in cmH2O/seconds), measured with an esophageal catheter, and the differences between start, during, and end of the SBT.
10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
Differences of rapid shallow breathing index during SBT
Time Frame: 10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT
The values of rapid shallow breathing index (breaths/minute/liter) and the differences between start, during, and end of the SBT.
10 minutes before, through SBT (average of 30 minutes) and 10 minutes after SBT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abraham Schoe, MD PhD, Leiden University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

December 15, 2023

First Submitted That Met QC Criteria

April 29, 2024

First Posted (Actual)

April 30, 2024

Study Record Updates

Last Update Posted (Actual)

April 30, 2024

Last Update Submitted That Met QC Criteria

April 29, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P23.068

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Data will be shared upon request with researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Illness

Clinical Trials on Spontaneous Breathing Trial

3
Subscribe